Geneseeq, a Chinese genetic testing company that focuses on treatments for cancer, has raised RMB800 million ($115 million) in a funding round led by state-owned China Reform Holding Corporation.
Lilly Asia Ventures, SBCVC, Everest Venture Capital Investment, E Fund Management, and Swiss China Corporation also contributed capital. Geneseeq specializes in next-generation sequencing (NGS) for precision...
Rob Kaplan is CEO of Singapore’s Circulate Capital, which is dedicated to reducing oceanic plastic pollution. Its $150 million debut fund is backed by the likes of Coca-Cola, PepsiCo, and Unilever
Australia’s Blackbird Ventures has raised A$500 million ($357 million) for its fourth fund and named Atlassian co-founder Mike Cannon-Brookes as chairman.
Yaoyanshe, a Chinese contract research organization (CRO) for novel drugs, has raised RMB600 million ($86 million) across two rounds in the past eight months.
MyGlamm, an online Indian cosmetics brand, has agreed to acquire POPxo, a women-focused content platform, for an undisclosed sum. Both companies have several VC backers.